Picture of Veracyte logo

VCYT — Veracyte News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousLarge CapHigh Flyer

Veracyte Inc reports results for the quarter ended in March - Earnings Summary

* Veracyte Inc  VCYT.OQ  reported a quarterly adjusted loss
of 20
cents​​ per share for the quarter ended in March. The mean
expectation of ten analysts for the quarter was for a loss of 24
cents per share.
    * Revenue rose 84.7% to $67.78 million from a year ago; 
analysts
expected $62.32 million. 
    * Veracyte Inc's reported EPS for the quarter was a loss
of 20
cents​.
    * The mean earnings estimate of analysts had fallen by
about 41.1%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Veracyte Inc shares had fallen by 21.7% this quarter and
lost 47.6% so far this year.
    * The company reported a quarterly loss of $14.46 million.
    * Wall Street's median 12-month price target for Veracyte
Inc is
$37.50 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 8 "strong buy" or "buy," 1
"hold" and 1 "sell" or "strong sell." 

This summary was machine generated May 4 at 03:08 a.m.  ​All
figures in US dollars unless otherwise stated

Recent news on Veracyte

See all news